Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Elinore McCance-Katz, MD, PhD

    TitleProfessor in Residence
    SchoolUCSF School of Medicine
    DepartmentPsychiatry
    AddressSFGH 7M-WD93
    1001 Potrero Avenue CA 94410
    Phone415-206-4010

       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Agerwala SM, McCance-Katz EF. Integrating screening, brief Intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review. J Psychoactive Drugs. 2012 Sep-Oct; 44(4):307-17.
        View in: PubMed
      2. Westermeyer J, McCance-Katz EF. Course and treatment of buprenorphine/naloxone withdrawal: an analysis of case reports. Am J Addict. 2012 Sep-Oct; 21(5):401-3.
        View in: PubMed
      3. McCance-Katz EF, Lum PJ, Beatty G, Gruber VA, Peters M, Rainey PM. Untreated HIV infection is associated with higher blood alcohol levels. J Acquir Immune Defic Syndr. 2012 Jul 1; 60(3):282-8.
        View in: PubMed
      4. Hochreiter J, McCance-Katz EF, Lapham J, Ma Q, Morse GD. Disulfiram metabolite S-methyl-N,N-diethylthiocarbamate quantitation in human plasma with reverse phase ultra performance liquid chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 15; 897:80-4.
        View in: PubMed
      5. McCance-Katz EF, Satterfield J. SBIRT: a key to integrate prevention and treatment of substance abuse in primary care. Am J Addict. 2012 Mar-Apr; 21(2):176-7.
        View in: PubMed
      6. Satre DD, McCance-Katz EF, Moreno-John G, Julian KA, O'Sullivan PS, Satterfield JM. Using needs assessment to develop curricula for screening, brief intervention, and referral to treatment (SBIRT) in academic and community health settings. Subst Abus. 2012; 33(3):298-302.
        View in: PubMed
      7. Satterfield JM, O'Sullivan P, Satre DD, Tsoh JY, Batki SL, Julian K, McCance-Katz EF, Wamsley M. Using standardized patients to evaluate screening, brief intervention, and referral to treatment (SBIRT) knowledge and skill acquisition for internal medicine residents. Subst Abus. 2012; 33(3):303-7.
        View in: PubMed
      8. Gruber VA, Rainey PM, Moody DE, Morse GD, Ma Q, Prathikanti S, Pade PA, Alvanzo AA, McCance-Katz EF. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. Clin Infect Dis. 2012 Feb 1; 54(3):414-23.
        View in: PubMed
      9. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46.
        View in: PubMed
      10. McCance-Katz EF, Moody DE, Prathikanti S, Friedland G, Rainey PM. Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients. Drug Alcohol Depend. 2011 Nov 1; 118(2-3):326-34.
        View in: PubMed
      11. Moody DE, Fang WB, Morrison J, McCance-Katz E. Gender differences in pharmacokinetics of maintenance dosed buprenorphine. Drug Alcohol Depend. 2011 Nov 1; 118(2-3):479-83.
        View in: PubMed
      12. McCance-Katz EF. (R)-methadone versus racemic methadone: what is best for patient care? Addiction. 2011 Apr; 106(4):687-8.
        View in: PubMed
      13. Heemskerk AA, van Haandel L, Woods JM, McCance-Katz EF, Williams TD, Stobaugh JF, Faiman MD. LC-MS/MS method for the determination of carbamathione in human plasma. J Pharm Biomed Anal. 2011 Mar 25; 54(4):799-806.
        View in: PubMed
      14. McCance-Katz EF. Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women. Life Sci. 2011 May 23; 88(21-22):953-8.
        View in: PubMed
      15. Gruber VA, McCance-Katz EF. Methadone, buprenorphine, and street drug interactions with antiretroviral medications. Curr HIV/AIDS Rep. 2010 Aug; 7(3):152-60.
        View in: PubMed
      16. Egan JE, Casadonte P, Gartenmann T, Martin J, McCance-Katz EF, Netherland J, Renner JA, Weiss L, Saxon AJ, Fiellin DA. The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment. J Gen Intern Med. 2010 Sep; 25(9):936-41.
        View in: PubMed
      17. Bruce RD, Kresina TF, McCance-Katz EF. Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users. AIDS. 2010 Jan 28; 24(3):331-40.
        View in: PubMed
      18. McCance-Katz EF, Moody DE, Morse GD, Ma Q, Rainey PM. Lack of clinically significant drug interactions between nevirapine and buprenorphine. Am J Addict. 2010 Jan-Feb; 19(1):30-7.
        View in: PubMed
      19. Maxwell JC, McCance-Katz EF. Indicators of buprenorphine and methadone use and abuse: what do we know? Am J Addict. 2010 Jan-Feb; 19(1):73-88.
        View in: PubMed
      20. McCance-Katz EF, Rainey PM, Moody DE. Effect of cocaine use on buprenorphine pharmacokinetics in humans. Am J Addict. 2010 Jan-Feb; 19(1):38-46.
        View in: PubMed
      21. McCance-Katz EF, Sullivan LE, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. Am J Addict. 2010 Jan-Feb; 19(1):4-16.
        View in: PubMed
      22. Boyer EW, McCance-Katz EF, Marcus S. Methadone and buprenorphine toxicity in children. Am J Addict. 2010 Jan-Feb; 19(1):89-95.
        View in: PubMed
      23. Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-Katz EF. Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir. Am J Addict. 2010 Jan-Feb; 19(1):17-29.
        View in: PubMed
      24. McCance-Katz EF, Mandell TW. Drug interactions of clinical importance with methadone and buprenorphine. Am J Addict. 2010 Jan-Feb; 19(1):2-3.
        View in: PubMed
      25. McCance-Katz EF, Jatlow P, Rainey PM. Effect of cocaine use on methadone pharmacokinetics in humans. Am J Addict. 2010 Jan-Feb; 19(1):47-52.
        View in: PubMed
      26. Fang WB, Chang Y, McCance-Katz EF, Moody DE. Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry. J Anal Toxicol. 2009 Oct; 33(8):409-17.
        View in: PubMed
      27. Kresina TF, Bruce RD, McCance-Katz EF. Medication assisted treatment in the treatment of drug abuse and dependence in HIV/AIDS infected drug users. Curr HIV Res. 2009 Jul; 7(4):354-64.
        View in: PubMed
      28. Moody DE, Chang Y, Huang W, McCance-Katz EF. The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism. Basic Clin Pharmacol Toxicol. 2009 Sep; 105(3):211-5.
        View in: PubMed
      29. McCance-Katz EF. [Commentary] Opioids and cardiogram abnormalities: providing treatment based on understanding the risks and benefits. Addiction. 2008 Dec; 103(12):1994-5.
        View in: PubMed
      30. Khalsa JH, Treisman G, McCance-Katz E, Tedaldi E. Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse. Subst Abus. 2008; 29(3):5-16.
        View in: PubMed
      31. McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM. Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend. 2007 Dec 1; 91(2-3):269-78.
        View in: PubMed
      32. DiFrancesco R, Fischl MA, Donnelly J, Zingman BS, McCance-Katz EF, Moody DE, Reichman RC, Gripshover B, Morse GD. Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users. J Pharm Biomed Anal. 2007 May 9; 44(1):188-95.
        View in: PubMed
      33. Baker J, Jatlow P, Pade P, Ramakrishnan V, McCance-Katz EF. Acute cocaine responses following cocaethylene infusion. Am J Drug Alcohol Abuse. 2007; 33(4):619-25.
        View in: PubMed
      34. Bruce RD, McCance-Katz E, Kharasch ED, Moody DE, Morse GD. Pharmacokinetic interactions between buprenorphine and antiretroviral medications. Clin Infect Dis. 2006 Dec 15; 43 Suppl 4:S216-23.
        View in: PubMed
      35. McCance-Katz EF, Moody DE, Smith PF, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Jatlow P, Rainey PM. Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir. Clin Infect Dis. 2006 Dec 15; 43 Suppl 4:S235-46.
        View in: PubMed
      36. McCance-Katz EF, Moody DE, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Smith P, Ogundele A, Jatlow P, Rainey PM. Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine. Clin Infect Dis. 2006 Dec 15; 43 Suppl 4:S224-34.
        View in: PubMed
      37. Baker JR, Jatlow P, McCance-Katz EF. Disulfiram effects on responses to intravenous cocaine administration. Drug Alcohol Depend. 2007 Mar 16; 87(2-3):202-9.
        View in: PubMed
      38. Huang W, Moody DE, McCance-Katz EF. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry. Ther Drug Monit. 2006 Apr; 28(2):245-51.
        View in: PubMed
      39. Baker JR, Best AM, Pade PA, McCance-Katz EF. Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients. Ann Pharmacother. 2006 Mar; 40(3):392-6.
        View in: PubMed
      40. McCance-Katz EF, Rainey PM, Smith P, Morse GD, Friedland G, Boyarsky B, Gourevitch M, Jatlow P. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine. Am J Addict. 2006 Jan-Feb; 15(1):23-34.
        View in: PubMed
      41. Chang Y, Moody DE, McCance-Katz EF. Novel metabolites of buprenorphine detected in human liver microsomes and human urine. Drug Metab Dispos. 2006 Mar; 34(3):440-8.
        View in: PubMed
      42. Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend. 2005 Aug 1; 79(2):157-65.
        View in: PubMed
      43. McCance-Katz EF. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents. Clin Infect Dis. 2005 Jul 1; 41 Suppl 1:S89-95.
        View in: PubMed
      44. McCance-Katz EF, Hart CL, Boyarsky B, Kosten T, Jatlow P. Gender effects following repeated administration of cocaine and alcohol in humans. Subst Use Misuse. 2005; 40(4):511-28.
        View in: PubMed
      45. Britt GC, McCance-Katz EF. A brief overview of the clinical pharmacology of "club drugs". Subst Use Misuse. 2005; 40(9-10):1189-201.
        View in: PubMed
      46. Draper JC, McCance-Katz EF. Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment. Subst Use Misuse. 2005; 40(13-14):1899-921, 2043-8.
        View in: PubMed
      47. McCance-Katz EF. Introduction to special issue "addiction pharmacotherapy and special populations". Subst Use Misuse. 2005; 40(13-14):1895-7.
        View in: PubMed
      48. McCance-Katz EF. Office-based buprenorphine treatment for opioid-dependent patients. Harv Rev Psychiatry. 2004 Nov-Dec; 12(6):321-38.
        View in: PubMed
      49. Nich C, McCance-Katz EF, Petrakis IL, Cubells JF, Rounsaville BJ, Carroll KM. Sex differences in cocaine-dependent individuals' response to disulfiram treatment. Addict Behav. 2004 Aug; 29(6):1123-8.
        View in: PubMed
      50. McCance-Katz EF, Rainey PM, Smith P, Morse G, Friedland G, Gourevitch M, Jatlow P. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir. Am J Addict. 2004 Mar-Apr; 13(2):163-80.
        View in: PubMed
      51. McCance-Katz EF. Well-intentioned, but potentially spreading the virus. Subst Use Misuse. 2003 Dec; 38(14):2127-9.
        View in: PubMed
      52. McCance-Katz EF, Rainey PM, Friedland G, Jatlow P. The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis. 2003 Aug 15; 37(4):476-82.
        View in: PubMed
      53. Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend. 2003 Jun 5; 70(3):315-25.
        View in: PubMed
      54. Oliveto A, Sevarino K, McCance-Katz E, Benios T, Poling J, Feingold A. Clonidine and yohimbine in opioid-dependent humans responding under a naloxone novel-response discrimination procedure. Behav Pharmacol. 2003 Mar; 14(2):97-109.
        View in: PubMed
      55. Oliveto A, Sevarino K, McCance-Katz E, Feingold A. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure. Pharmacol Biochem Behav. 2002 Jan-Feb; 71(1-2):85-96.
        View in: PubMed
      56. Rainey PM, Friedland GH, Snidow JW, McCance-Katz EF, Mitchell SM, Andrews L, Lane B, Jatlow P. The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects. Am J Addict. 2002; 11(1):66-74.
        View in: PubMed
      57. McCance-Katz EF, Gourevitch MN, Arnsten J, Sarlo J, Rainey P, Jatlow P. Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J Addict. 2002; 11(4):271-8.
        View in: PubMed
      58. McCance-Katz EF, Kosten TA, Kosten TR. Going from the bedside back to the bench with ecopipam: a new strategy for cocaine pharmacotherapy development. Psychopharmacology (Berl). 2001 Jun; 155(4):327-9.
        View in: PubMed
      59. McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P. Effect of opioid dependence pharmacotherapies on zidovudine disposition. Am J Addict. 2001; 10(4):296-307.
        View in: PubMed
      60. Singha AK, McCance-Katz EF, Petrakis I, Kosten TR, Oliveto A. Sex differences in self-reported and physiological response to oral cocaine and placebo in humans. Am J Drug Alcohol Abuse. 2000 Nov; 26(4):643-57.
        View in: PubMed
      61. Boyarsky BK, McCance-Katz EF. Improving the quality of substance dependency treatment with pharmacotherapy. Subst Use Misuse. 2000 Oct-Dec; 35(12-14):2095-125.
        View in: PubMed
      62. Rainey PM, Friedland G, McCance-Katz EF, Andrews L, Mitchell SM, Charles C, Jatlow P. Interaction of methadone with didanosine and stavudine. J Acquir Immune Defic Syndr. 2000 Jul 1; 24(3):241-8.
        View in: PubMed
      63. Hart CL, Jatlow P, Sevarino KA, McCance-Katz EF. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology (Berl). 2000 Apr; 149(2):153-62.
        View in: PubMed
      64. McCance-Katz EF, Farber S, Selwyn PA, O'Connor A. Decrease in methodone levels with nelfinavir mesylate. Am J Psychiatry. 2000 Mar; 157(3):481.
        View in: PubMed
      65. Petrakis IL, Carroll KM, Nich C, Gordon LT, McCance-Katz EF, Frankforter T, Rounsaville BJ. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction. 2000 Feb; 95(2):219-28.
        View in: PubMed
      66. Winther LC, Saleem R, McCance-Katz EF, Rosen MI, Hameedi FA, Pearsall HR, Jatlow PI, Kosten TR, Woods SW. Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. Am J Drug Alcohol Abuse. 2000 Feb; 26(1):47-59.
        View in: PubMed
      67. Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry. 2000 Jan; 5(1):56-63.
        View in: PubMed
      68. Singha AK, McCance-Katz EF, Heck SA, Kosten TR, Oliveto A. Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Exp Clin Psychopharmacol. 1999 Nov; 7(4):391-8.
        View in: PubMed
      69. McCance-Katz E, Sevarino K, Gottschalk PC, Kosten T. Pharmacotherapy of stimulant dependence: one of Japan's greatest public health challenges. Nihon Shinkei Seishin Yakurigaku Zasshi. 1999 Oct; 19(4):159-86.
        View in: PubMed
      70. McCance-Katz EF, Carroll KM, Rounsaville BJ. Gender differences in treatment-seeking cocaine abusers--implications for treatment and prognosis. Am J Addict. 1999; 8(4):300-11.
        View in: PubMed
      71. McCance-Katz EF, Kosten TR, Jatlow P. Disulfiram effects on acute cocaine administration. Drug Alcohol Depend. 1998 Sep 1; 52(1):27-39.
        View in: PubMed
      72. McCance-Katz EF, Kosten TR, Jatlow P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone--a multiple-dose study. Biol Psychiatry. 1998 Aug 15; 44(4):250-9.
        View in: PubMed
      73. McCance-Katz EF, Rainey PM, Jatlow P, Friedland G. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):435-43.
        View in: PubMed
      74. Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behav Pharmacol. 1998 May; 9(3):207-17.
        View in: PubMed
      75. McCance-Katz EF, Kosten TR, Jatlow P. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol Psychiatry. 1998 Apr 1; 43(7):540-3.
        View in: PubMed
      76. Price LH, Malison RT, McDougle CJ, McCance-Katz EF, Owen KR, Heninger GR. Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP). Neuropsychopharmacology. 1997 Nov; 17(5):342-50.
        View in: PubMed
      77. Hameedi FA, Rosen MI, McCance-Katz EF, McMahon TJ, Price LH, Jatlow PI, Woods SW, Kosten TR. Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans. Biol Psychiatry. 1995 Apr 15; 37(8):560-3.
        View in: PubMed
      78. McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1993 Apr; 150(4):647-9.
        View in: PubMed
      79. McCance-Katz EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 1993; 111(1):39-46.
        View in: PubMed
      80. McCance-Katz EF, Marek KL, Price LH. Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology. 1992 Sep; 42(9):1813-4.
        View in: PubMed
      81. McCance-Katz EF, Price LH. Depression associated with vitamin A intoxication. Psychosomatics. 1992; 33(1):117-8.
        View in: PubMed
      82. McCance-Katz E, Price LH, Charney DS, Heninger GR. Serotonergic function during lithium augmentation of refractory depression. Psychopharmacology (Berl). 1992; 108(1-2):93-7.
        View in: PubMed
      83. McCance-Katz EF. New onset Raynaud's phenomenon in a schizophrenic patient. J Clin Psychiatry. 1991 Feb; 52(2):89-90.
        View in: PubMed
      84. McCance-Katz EF. The consequences of maternal substance abuse for the child exposed in utero. Psychosomatics. 1991; 32(3):268-74.
        View in: PubMed
      85. McCance-Katz EF, Hoecker JL, Vitale NB. Severe neutropenia associated with anti-neutrophil antibody in a patient with acquired immunodeficiency syndrome-related complex. Pediatr Infect Dis J. 1987 Apr; 6(4):417-8.
        View in: PubMed
      Elinore's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (324) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (12) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP